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Double frameshift mutations in APC and MSH2
in the same individual
Abstract Heterozygous germline
DNA mismatch repair gene mutations
are typically associated with HNPCC.
Here we report the case of a proband
whose father was known for familial
adenomatous polyposis. The number of
polyps (<10) was not typical of polyp-
osis, therefore the diagnosis of HNPCC
was entertained. Microsatellite in-
stability analyses were performed on
peripheral blood and biopsy of a right-
sided dysplastic adenoma. The tumour
tissue showed high-grade instability
and subsequently immunohistochem-
istry showed that neither MSH2 nor
MSH6 proteins were expressed in
tumour cells. Prophylactic colectomy
was performed and an adenocarcinoma
developing within the adenoma was
diagnosed (pT1N0). Genomic DNA
analysis revealed a novel mutation in
MSH2 as: a frameshift mutation in exon
7 (c.1,191_1,192dupG). Both parents
of the proband were analyzed for
MSH2 and APC mutations, and in the
father a truncating mutation in exon 15
of APC was identified as del3471-
3473GAGA. This mutation was found
to be present in the proband. His
mother was found to bear the MSH2
exon 7 mutation. At follow-up, the
proband was diagnosed with fundic,
antral and duodenal adenomas (one
fundic adenoma showed low-grade
dysplasia). Several tubular rectal ade-
nomas with low-grade dysplasia were
excised. The patient later developed an
intra-abdominal desmoid tumour.
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Introduction
Among the known genetic predispositions to cancer syn-
dromes, two confer a high risk of colorectal cancer (CRC).
Familial adenomatous polyposis (FAP), generally due to
mutations in theAPC gene on chromosome 5, is responsible
for approximately 1% of all CRC. Mutations in at least four
mismatch repair (MMR) genes, MLH1, MSH2, MSH6 and
PMS2, result in Lynch syndrome, or HNPCC (hereditary
nonpolyposis colorectal cancer); together these MMR gene
mutations account for 3–5% of all CRC [1–3]. Given the
relatively high incidence of these conditions, one would
expect an occasional individual to be homozygous for the
two APC or two MMR mutations, or to be a carrier of
compound heterozygous germline mutations in APC and
MMR genes [4–9] Table 1.
To our knowledge however, the present case is the first
patient observed with concomitant inheritance of patho-
genic frameshift mutations in APC and MSH2.
We report here a complete description of this family with
5-year follow-up of the proband. As he presented fewer
polyps than expected at age 25 in a patient with FAP: the
differential diagnosis was between HNPCC and attenuated
FAP (AFAP) [10, 11].
Case report
The proband, a 24-year-old man, consulted because of a
history of FAP in his father and at least seven othermembers
of his southern Italian family (Fig. 1). His father’s medical
record was not available when this study begun and no
genetic testing had been performed. Five polyps were
detected on ileocoloscopy, two in the right colon and three
in the sigmoid; four of the polyps were adenomas, one of
which was dysplastic.
As the number of polyps was not typical of polyposis, the
diagnosis of HNPCC was entertained. Microsatellite in-
stability analysis was performed on DNA from dysplastic
adenoma and from peripheral blood. The tumour tissue
showed high-grade instability (MSI-H) at all four markers
tested: BAT25, BAT26, D2S123 and D5S346. IHC on four
DNA mismatch repair proteins was also performed. MSH2
andMSH6were not expressed in tumor cells, whereasMLH1/
PMS2 expression was conserved.
Genetic analysis started with MSH2 and bidirectional se-
quencing of the exons and the intron–exon junctions using
amplification products obtained by PCR from genomic
DNA. A novel mutation was identified inMSH2: insertion
of a G in codon 398, in exon 7 at position 1,191 (c.1,
191_1,192dupG), had created a premature termination 19
codons downstream.
The patient opted for prophylactic surgery at age 25 and
underwent total colectomy with ileo–rectal anastomosis.
In the prophylactic colectomy specimen, a small well-dif-
ferentiated adenocarcinoma (pT1N0), developing from a
tubulo–villous adenoma was found in the right colon, along
with “multiple” flat adenomas and associated aberrant crypts.
No intra-abdominal desmoid tumour was found at this time.
Over the last 4 years, the patient has experienced nu-
merous complications: soon after colectomy, he had fre-
quent episodes of gastro–esophageal reflux which were
temporarily lessened by a proton-pump inhibitor (panto-
prazol). At the age of 25 oeso–gastroduodenoscopy showed
chronic gastritis (negative for Helicobacter pylori), hiatal
hernia and approximately 30 fundic polyps. Out of three
adenomas excised from duodenum, antrum, and gastric
fundus, the latter showed low-grade dysplasia. Rectoscopies
were carried out at 3-month intervals over the following
year, and showed the presence of two to nine polyps, at least
one of which was a tubular adenoma with mild dysplasia.
The patient was placed on rofecoxib in an attempt to reduce
polyp development, but micro-perforations led to peritoni-
tis and emergency surgery. On this occasion, a mesenteric
desmoid tumour was diagnosed from biopsy. To eliminate
the risk of additional rectal cancer a proctectomy with endo-
anal mucosectomy, and implementation of a pelvic pouch
procedure was proposed, but was declined by the patient.
Bi-annual rectoscopy and esogastroduodenoscopy are
currently carried out as surveillance. At his most recent
examination (at age 28), the proband presented with fewer
than ten rectal polyps (one serrated adenoma) but presented
multiple gastric fundic polyps (excised polyp was adenoma
with low-grade dysplasia).
At the time of their son’s surgery for colectomy both
parents consulted. As already mentioned, the father pre-
sented with familial adenomatous polyposis (FAP); he had
undergone colectomy at age 53 after FAP with colon
carcinoma was diagnosed. An APC gene mutation search
was initiated in our laboratory. PTT detected a truncating
mutation in exon 15, then caracterized as c.del3471_3474-
GAGA. This frameshift mutation creates a premature stop
Table 1 Summary of reported families with APC and MMR germline
mutations
References Genes
involved
Clinical findings
Scheenstra et al.
(2003) [9]
APC,
MLH1
10-year old with symptomatic FAP,
rapid progression of adenomas
Yuan et al.
(1998) [7]
APC,
MLH1
APC polymorphism I1307K; family not
of Jewish origin; does not segregate
with HNPCC disease phenotype
Yuan et al.
(1999) [8]
APC,
MSH2
APC polymorphism I1307K; Ashkenazi
Jewish individual; variant does not
segregate with HNPCC disease
phenotype
Present case
(2004)
APC,
MSH2
Right-sided polyps (AFAP), but early
age of CRC (24), gastric and rectal
adenomas with dysplasia
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codon six codons downstream. His son (the proband), car-
rying theMSH2 exon 7 mutation, was found to have inher-
ited the APC exon 15 mutation from his father. The MSH2
mutation was absent in the father.
We then analyzed the proband’s 53-year-old mother, who
had no significant medical history but had not undergone
colonoscopy, carries theMSH2mutation. Clinical screening
for digestive and gynecological pathologies was recom-
mended. Of her seven siblings, a brother reportedly died of
colon cancer in his fifties and a sister of uterine cancer at
age 62. Genetic testing was offered to all at-risk family
members.
Discussion
At the age of 25, the proband’s clinical presentation was
more suggestive of HNPCC or possibly AFAP than of clas-
sical FAP, on both clinical and histological grounds. This
observation, along with the lack of confirmatory medical
records about his father, led us to perform screening tests
(MSI, IHC) for HNPCC. The proband was found to harbour
two germline mutations predisposing to CRC: an APC exon
15 frameshift mutation inherited from his father and a
frameshift mutation in MSH2, inherited from his mother.
Upon further evaluation, the proband showed clinical
characteristics of both disorders: desmoid tumours are
indicative of FAP, and the small number of polyps in the
proximal colon (less than ten) was suggestive of AFAP or
HNPCC. His clinical course has, however, been relatively
severe, with an adenocarcinoma of the right colon diag-
nosed at age 25, and the postoperative development of a
mesenteric desmoid tumour. Desmoid tumours occur in
80%of individualswith FAPwho undergo prophylactic colon
surgery [14]. Several studies have demonstrated an increased
risk for desmoid tumours, in patients with APC mutations
occuring between codons 1,310 and 2,011 [12–14]. In our
patient, the APC mutation is located at codon 1,157 and
there is no family history of desmoids in this kindred.
Gastric adenoma and/or cancer has been described in
both AFAP and HNPCC [15–17]. Helicobacter pylori in-
fection may induce atrophic gastritis in FAP patients and
trigger adenoma development, but our patient tested neg-
ative for Helicobacter pylori. As gastric cancer/dysplasia is
part of the HNPCC tumour spectrum, MLH1 and MSH2
mutations may influence gastric cancer progression.
A more aggressive clinical course has been reported in
the handful of reported patients with both APC and a second
predisposing mutation in a different gene. Zajac and col-
leagues [18] reported an 18-year-old with inherited FAP and
>1,000 polyps. The familial mutation, upstream from the
mutation cluster region in the APC gene, had not been asso-
ciated with a particularly severe phenotype in this family.
Because of the proband’s clinical severity a search for ad-
ditional mutations was undertaken and a germline p53 mu-
tation identified. The authors hypothesized that the mother,
who died at age 28 of uterine carcinoma, may have also had
double mutations.
The only other patient reported to harbor concomitant
mutations in APC and a MMR gene was a 10-year-old child
with symptomatic polyposis; the APC mutation was a ma-
ternally-inherited prevalent frameshift in exon 15, and the
paternally-inherited MMR mutation was a splice site mu-
tation inMLH1 [9]. The authors hypothesized that the rapid
progression to high-grade adenomas in this patient was due
to the influence of the MLH1 mutation; high-grade dys-
plasia was associated with loss ofMLH1 expression by IHC
criteria. Surely, the severe phenotype may simply be a re-
flection of the clinical variability seen in both FAP and
HNPCC.
It is worth noting that in mice that are compound het-
erozygotes for APC and MLH1 germline mutations, cancer
phenotypes are also enhanced [19, 20].
53 y
d. >75 d.  >75
colon CA
age 53d. 53
d. 62
* #
#
*
Fig. 1 Proband’s family pedi-
gree with APC and MSH2
germline mutations. Pedigree of
the family segregating an APC
mutation (father of proband) and
MSH2 mutation (mother of pro-
band). Half-filled symbols indi-
cate colon cancer, filled gray
symbols endometrial cancer and
horizontal lines clinical polypo-
sis coli. Proven APC mutation
carriers have an * and proven
MSH2 mutation carriers an #.
The arrow indicates the proband
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Two families have been described [7, 8] with an MMR
gene mutation plus the APC missense variant I1307K. The
latter change, present in 6% of the Jewish population, does
not result in FAP, but in some individuals appears to pre-
dispose to colorectal polyps, as a possible result of hyper-
mutability of the altered region of theAPC gene; the relative
risk of CRC with the I1307K polymorphism has been
reported as 1.5–2.0 [21]. In the first of the two families, a
French Canadian CRC kindred with an MLH1 truncating
mutation, there was no clear association between the APC
I1307K polymorphism and the development of cancer [7].
The same was true in a second such family, of Ashkenazi
origin, which fulfilled the Amsterdam criteria for HNPCC.
Affected individuals had a missense mutation of MSH2,
which was later proven to be pathogenic [22]; however, pres-
ence or absence of the APC I1307K genotype did not cor-
relate with disease. Thus, in these two families, one clear
mutation (in aMMRgene which correlated with the HNPCC
phenotype) was defined, whereas the APC polymorphism
was transmitted independently of the CRC phenotype.
Kinzler and Vogelstein [23] proposed that the APC gene
serves as the “gatekeeper” of epithelial proliferation, thus
exerting a major influence on initiation of the neoplastic
process. By contrast, theMMRmutations underlyingHNPCC
alter “caretaker” genes, and would accelerate carcinogen-
esis, once the initiation step has occurred. However, the
distinction between gatekeeper and caretaker roles has
recently become somewhat blurred, as the mutation of APC
could not be shown to be a compulsory step in all CRC.
Indeed, a significant proportion of colorectal cancer may
be initiated through the epigenetic silencing of alternative
genes implicated in apoptosis and mismatch repair [24].
In dysplastic microscopic epithelial lesions referred to as
aberrant crypt foci (ACF), flat tubular adenomas, and pol-
ypoid tubular adenomas, the frequency of APCmutations is
reported to be 0, 7 and 36%, respectively [25]. Moreover,
genomic instability has actually been detected in ACF. These
observations led to two contrasting hypotheses: a “dysplasia
ACF–adenoma–carcinoma sequence”, or a “heteroplastic
ACF–adenoma–carcinoma sequence”. These observations
may suggest the APC mutation consistently triggers ad-
enoma formation before theMSH2mutation participates in
tumorigenesis through MSI. Molecular analysis of ACF or
the demonstration that very early adenomas show abnor-
mal expression of beta-catenin [26], should help to clarifiy
this issue.
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